Gene: PTN

5764
HARP|HB-GAM|HBBM|HBGF-8|HBGF8|HBNF|HBNF-1|NEGF1|OSF-1
pleiotrophin
protein-coding
7q33
Ensembl:ENSG00000105894 MIM:162095 Vega:OTTHUMG00000155709 UniprotKB:P21246
NC_000007.14
PubMed
0   ANCO-SNPs
OD|ND
3   
NA (AD)  NA (ND)   (Frontal_Cortex)
3.531e-1 (AD)  6.286e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
HADHB0.912
GLUD10.9
GLUL0.894
SRI0.893
ALDH20.89
PSAT10.886
ASRGL10.883
PON20.883
EZR0.882
HTRA10.874

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
OR4F5-0.656
OR4F29-0.642
PROKR2-0.377
CACNA1F-0.358
IL12RB2-0.349
NPBWR2-0.347
NRG1-0.34
THEM5-0.339
FBXO40-0.335
GDF7-0.335

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C0326681-nitropyrene1-nitropyrene results in decreased expression of PTN mRNA19041380
C0303702-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in increased expression of PTN mRNA"20206263
C0230353,4,5,3',4'-pentachlorobiphenyl"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of PTN mRNA"28973690
C0230353,4,5,3',4'-pentachlorobiphenyl"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of PTN mRNA"23196670
C0095054,4'-diaminodiphenylmethane"4,4'-diaminodiphenylmethane results in decreased expression of PTN mRNA"25380136
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PTN mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PTN mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PTN mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PTN mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PTN mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PTN mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PTN mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PTN mRNA"27188386
D016604Aflatoxin B1Aflatoxin B1 affects the expression of PTN protein20106945
D000643Ammonium ChlorideAmmonium Chloride affects the expression of PTN mRNA16483693
D000661AmphetamineAmphetamine inhibits the reaction [PTN gene mutant form results in decreased expression of ENO2 protein]23459167
D000661AmphetamineAmphetamine promotes the reaction [PTN gene mutant form results in decreased expression of ATP5A1 protein]23459167
D000661AmphetaminePTN gene mutant form inhibits the reaction [Amphetamine results in decreased expression of ATP5D protein]23459167
D000661AmphetaminePTN gene mutant form results in decreased susceptibility to Amphetamine23459167
D000661Amphetamine[PTN gene mutant form results in decreased susceptibility to Amphetamine] which results in increased expression of and results in increased phosphorylation of ERP29 protein23459167
D000661Amphetamine[PTN gene mutant form results in increased susceptibility to Amphetamine] which results in decreased expression of ANXA7 protein23459167
D000661AmphetaminePTN protein inhibits the reaction [Amphetamine results in decreased expression of TH protein]20620199
D000661AmphetaminePTN protein inhibits the reaction [Amphetamine results in decreased phosphorylation of MAPK3 protein]20620199
D000661AmphetaminePTN protein results in decreased susceptibility to Amphetamine20192945
D000661AmphetamineAmphetamine results in increased expression of PTN mRNA15862925
D000661AmphetamineDizocilpine Maleate promotes the reaction [Amphetamine results in increased expression of PTN mRNA]15862925
D000661AmphetamineAmphetamine results in increased expression of PTN protein20192945
D001151ArsenicArsenic results in decreased expression of PTN mRNA24019935
D001205Ascorbic AcidAscorbic Acid results in increased expression of PTN mRNA15305145
C030935benz(a)anthracenebenz(a)anthracene results in increased expression of PTN mRNA23656968
D019324beta-Naphthoflavone[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PTN mRNA18164116
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of PTN mRNA20713471|2222880
D0151237,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of PTN mRNA"20382639
D004958Estradiol[bisphenol A co-treated with Estradiol] results in increased expression of PTN mRNA26496021
C006780bisphenol Abisphenol A affects the expression of PTN mRNA21786754
C006780bisphenol Abisphenol A results in increased expression of PTN mRNA27685785
C006780bisphenol A[bisphenol A co-treated with Estradiol] results in increased expression of PTN mRNA26496021
C006780bisphenol Abisphenol A results in decreased expression of PTN mRNA25181051
C005961bis(tri-n-butyltin)oxidebis(tri-n-butyltin)oxide results in decreased expression of PTN mRNA18958704
C018475butyraldehydebutyraldehyde results in increased expression of PTN mRNA26079696
D019256Cadmium ChlorideCadmium Chloride results in decreased expression of PTN mRNA12160620
D019256Cadmium Chloride[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of PTN mRNA19840844
D002251Carbon TetrachlorideCarbon Tetrachloride results in increased expression of PTN mRNA11999218|1838159
D002273CarcinogensCarcinogens results in increased expression of PTN mRNA16316942
D002713ChlorineChlorine results in increased expression of PTN mRNA18636392
D002713Chlorine[Ozone co-treated with Chlorine] results in increased expression of PTN mRNA18636392
D020245p-Chloromercuribenzoic Acid"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PTN mRNA"27188386
D020245p-Chloromercuribenzoic Acidp-Chloromercuribenzoic Acid results in decreased expression of PTN mRNA26272509
D002809Chondroitin SulfatesChondroitin Sulfates analog binds to PTN protein12221095
D002809Chondroitin Sulfates[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to PTN protein15385557
D002809Chondroitin Sulfates[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to PTN protein14699094
D003042CocaineCocaine results in decreased expression of PTN mRNA12629581
D003042CocaineCocaine affects the reaction [PTN affects the expression of PDIA3 protein modified form]24096156
D016578Crack CocaineCrack Cocaine results in increased expression of PTN mRNA12629581
D003513CycloheximideCycloheximide results in increased expression of PTN mRNA19684285
D003513Cycloheximide[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of PTN mRNA19684285
D016572CyclosporineCyclosporine results in decreased expression of PTN mRNA20106945
D013759DronabinolDronabinol results in increased expression of PTN mRNA16616335|7970205
D003871Dermatan Sulfate[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to PTN protein15385557
D003871Dermatan Sulfate[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to PTN protein14699094
D003976DiazinonDiazinon affects the expression of PTN mRNA22546817
D004026DieldrinDieldrin affects the expression of PTN mRNA22546817
D004052Diethylnitrosamine[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PTN mRNA18164116
D004054DiethylstilbestrolDiethylstilbestrol results in decreased expression of PTN mRNA15591538
D002117CalcitriolCalcitriol results in decreased expression of PTN mRNA21153232
D002117CalcitriolCalcitriol results in decreased expression of PTN mRNA21153232
D002117CalcitriolCalcitriol results in increased expression of PTN mRNA21153232
D004128DimethylnitrosamineDimethylnitrosamine results in decreased expression of PTN mRNA25380136
D016291Dizocilpine MaleateDizocilpine Maleate promotes the reaction [Amphetamine results in increased expression of PTN mRNA]15862925
D004610Ellagic AcidEllagic Acid results in decreased expression of PTN mRNA12002526
D004610Ellagic AcidEllagic Acid results in increased expression of PTN mRNA12002526
D004997Ethinyl EstradiolEthinyl Estradiol results in decreased expression of PTN mRNA17555576
D004997Ethinyl Estradiol[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of PTN mRNA17942748
D004997Ethinyl EstradiolEthinyl Estradiol results in decreased expression of PTN mRNA15834898|1755790
D0150732-Acetylaminofluorene2-Acetylaminofluorene results in increased expression of PTN mRNA12057922
C039281furanfuran results in increased expression of PTN mRNA27387713
D005665FurosemideFurosemide affects the expression of PTN mRNA16526316
D005688GalactosamineGalactosamine results in increased expression of PTN mRNA12057922
D005688GalactosamineGalactosamine results in increased expression of PTN protein12057922
D005947Glucose[INS protein co-treated with Glucose] results in increased expression of PTN mRNA22634610
C561695(+)-JQ1 compound(+)-JQ1 compound results in increased expression of PTN mRNA27432991
D008748MethylcholanthreneMethylcholanthrene results in decreased expression of PTN mRNA20713471
D008769Methylnitronitrosoguanidine[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of PTN mRNA19840844
D008769Methylnitronitrosoguanidine[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of PTN mRNA19840844
D008769Methylnitronitrosoguanidine[Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of PTN mRNA19840844
D0156551-Methyl-4-phenylpyridinium1-Methyl-4-phenylpyridinium results in decreased expression of PTN mRNA24810058
C523799MRK 003PTN results in decreased susceptibility to MRK 00319903844
D0150581-Naphthylisothiocyanate1-Naphthylisothiocyanate results in decreased expression of PTN mRNA25380136
D009532NickelNickel results in decreased expression of PTN mRNA24768652|2558310
C014707nitrosobenzylmethylaminenitrosobenzylmethylamine results in decreased expression of PTN mRNA17616710
D019319Okadaic Acid[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of PTN mRNA19840844
C030110oxaliplatin[oxaliplatin co-treated with Topotecan] results in increased expression of PTN mRNA25729387
C030110oxaliplatinoxaliplatin results in increased expression of PTN mRNA25729387
D010126Ozone[Ozone co-treated with Chlorine] results in increased expression of PTN mRNA18636392
D010269ParaquatParaquat results in increased expression of PTN mRNA26345256
C086401pentabromodiphenyl etherpentabromodiphenyl ether results in decreased expression of PTN mRNA26705709
D010416PentachlorophenolPentachlorophenol results in increased expression of PTN mRNA23892564
C101814perfluoro-n-undecanoic acidperfluoro-n-undecanoic acid results in decreased expression of PTN mRNA23602845
C023036perfluorooctanoic acidperfluorooctanoic acid results in decreased expression of PTN mRNA19162173
D010662Phenylmercuric Acetate"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PTN mRNA"27188386
D011374ProgesteroneProgesterone results in decreased expression of PTN mRNA23012394
D011374ProgesteroneProgesterone results in increased expression of PTN mRNA20631399
D011374ProgesteroneProgesterone results in decreased expression of PTN mRNA20864642
D011441PropylthiouracilPropylthiouracil results in increased expression of PTN mRNA24780913
C014175pyrazolo(3,4-d)pyrimidine"pyrazolo(3,4-d)pyrimidine analog affects the expression of PTN mRNA"21152443
C014175pyrazolo(3,4-d)pyrimidine"pyrazolo(3,4-d)pyrimidine analog affects the expression of PTN mRNA"21152443
D012834SilverSilver results in decreased expression of PTN mRNA27131904
C017947sodium arsenitesodium arsenite affects the methylation of PTN gene28589171
D053260SootSoot results in decreased expression of PTN mRNA26551751
D013629TamoxifenTamoxifen affects the expression of PTN mRNA14699072
D013629TamoxifenTamoxifen affects the expression of PTN mRNA17555576
C004648testosterone enanthatetestosterone enanthate affects the expression of PTN mRNA17440010
D013749Tetrachlorodibenzodioxin[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of PTN mRNA19684285
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of PTN mRNA19684285
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of PTN mRNA21570461
D013749Tetrachlorodibenzodioxin[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of PTN mRNA17942748
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of PTN mRNA17942748
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of PTN mRNA20959002|2121527
D013755Tetradecanoylphorbol Acetate[Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of PTN mRNA19840844
D019772Topotecan[oxaliplatin co-treated with Topotecan] results in increased expression of PTN mRNA25729387
D019772TopotecanTopotecan results in increased expression of PTN mRNA25729387
D014118Toxins, Biological"Toxins, Biological affects the expression of PTN mRNA"19682533
D014212TretinoinTretinoin results in decreased expression of PTN mRNA21934132
D014212TretinoinTretinoin results in increased expression of PTN mRNA23724009
C012589trichostatin A"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PTN mRNA"27188386
C012589trichostatin Atrichostatin A results in increased expression of PTN mRNA24935251|2627250
C015559trimellitic anhydridetrimellitic anhydride results in decreased expression of PTN mRNA19042947
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PTN mRNA"27188386
D014635Valproic AcidValproic Acid results in decreased expression of PTN mRNA28001369
D014635Valproic AcidValproic Acid results in increased expression of PTN mRNA23179753|2438349
C111237vorinostatvorinostat results in increased expression of PTN mRNA26272509

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0004864protein phosphatase inhibitor activity-TAS10706604  
GO:0008083growth factor activity-IBA21873635  
GO:0008083growth factor activity-IDA1733956  
GO:0008201heparin binding-IDA1733956  
GO:0019901protein kinase binding-IPI20873783  
GO:0035373chondroitin sulfate proteoglycan binding-IEA-  
GO:0035374chondroitin sulfate binding-IDA26896299  
GO:0038085vascular endothelial growth factor binding-IEA-  
GO:1904399heparan sulfate binding-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0001889liver development-IEA-  
GO:0007185transmembrane receptor protein tyrosine phosphatase signaling pathway-TAS10706604  
GO:0007399nervous system development-TAS2270483  
GO:0007507heart development-IEA-  
GO:0007612learning-IEA-  
GO:0008284positive regulation of cell proliferation-IDA1733956  
GO:0008360regulation of cell shape-IEA-  
GO:0010469regulation of signaling receptor activity-IEA-  
GO:0010811positive regulation of cell-substrate adhesion-IEA-  
GO:0010976positive regulation of neuron projection development-IEA-  
GO:0014823response to activity-IEA-  
GO:0016525negative regulation of angiogenesis-IEA-  
GO:0021510spinal cord development-IEA-  
GO:0021549cerebellum development-IEA-  
GO:0021794thalamus development-IEA-  
GO:0030282bone mineralization-IEA-  
GO:0030324lung development-IEA-  
GO:0030336negative regulation of cell migration-IEA-  
GO:0032355response to estradiol-IEA-  
GO:0032515negative regulation of phosphoprotein phosphatase activity-IEA-  
GO:0032570response to progesterone-IEA-  
GO:0034644cellular response to UV-IEA-  
GO:0036120cellular response to platelet-derived growth factor stimulus-IEA-  
GO:0043065positive regulation of apoptotic process-IEA-  
GO:0044849estrous cycle-IEA-  
GO:0045446endothelial cell differentiation-IEA-  
GO:0045837negative regulation of membrane potential-IEA-  
GO:0050680negative regulation of epithelial cell proliferation-IEA-  
GO:0051781positive regulation of cell division-IEA-  
GO:0060221retinal rod cell differentiation-IEA-  
GO:0060253negative regulation of glial cell proliferation-IEA-  
GO:0060291long-term synaptic potentiation-IEA-  
GO:0071305cellular response to vitamin D-IEA-  
GO:0071456cellular response to hypoxia-IEA-  
GO:0072201negative regulation of mesenchymal cell proliferation-IEA-  
GO:1904373response to kainic acid-IEA-  
GO:1904389rod bipolar cell differentiation-IEA-  
GO:1904391response to ciliary neurotrophic factor-IEA-  
GO:1904395positive regulation of skeletal muscle acetylcholine-gated channel clustering-IEA-  
GO:1904397negative regulation of neuromuscular junction development-IEA-  
GO:1990089response to nerve growth factor-IEA-  
GO:2000347positive regulation of hepatocyte proliferation-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005576extracellular region-IBA21873635  
GO:0005604basement membrane-IEA-  
GO:0005615extracellular space-IDA1733956  
GO:0005783endoplasmic reticulum-IDA-  
GO:0009986cell surface-IEA-  
GO:0016020membrane-IEA-  
GO:0031594neuromuscular junction-IEA-  
GO:0032991protein-containing complex-IDA20873783  
GO:0048471perinuclear region of cytoplasm-IEA-  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
26164717Regulation of Pleiotrophin, Midkine, Receptor Protein Tyrosine Phosphatase beta/zeta, and Their Intracellular Signaling Cascades in the Nucleus Accumbens During Opiate Administration. (2015 Jul 11)Garcia-Perez DInt J Neuropsychopharmacol
26742526Acute Morphine, Chronic Morphine, and Morphine Withdrawal Differently Affect Pleiotrophin, Midkine, and Receptor Protein Tyrosine Phosphatase beta/zeta Regulation in the Ventral Tegmental Area. (2017 Jan)Garcia-Perez DMol Neurobiol
25464002Mortality after radical cystectomy: impact of obesity versus adiposity after adjusting for skeletal muscle wasting. (2015 May)Psutka SPJ Urol